SH-11037 is thus a safe and effective treatment for murine ocular neovascularisation, worthy of further mechanistic and pharmacokinetic evaluation. Neovascular eye diseases are a major cause of blindness throughout life. Between 6% and 18% of childhood blindness is attributable to retinopathy of ...